Atomera (ATOM) Earnings Date & Reports

Key Takeaways

• Atomera reported a net loss of $6.0 million, or ($0.15) per basic and diluted share, for the third quarter of 2026, compared with a net loss of $5.6 million, or ($0.17) per share, in the same quarter last year.
• Revenue was $0 in the third quarter, down from $11,000 a year earlier and $158,000 in the second quarter of 2026, underscoring the company's pre-royalty, licensing-stage profile.
• Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) was a loss of $4.6 million, compared with a $4.4 million loss in the third quarter of 2025.
• The company ended the quarter with $34.8 million in cash, cash equivalents, and short-term investments, up from $19.2 million at the end of 2025.
• Gate-all-around (GAA) customer engagements increased to three, and Atomera signed a joint development agreement with IQE to advance RF (radio frequency) gallium nitride (GaN) products.
• The reported loss per share of ($0.15) was wider than the ($0.12) consensus estimate tracked ahead of the release.
• For more detail on the company's Major News, Today's Price Move, Price Targets, and Forecast, explore Atomera's dedicated pages.
• To discover AI-driven trading strategies, explore Trending AI Robots.

Earnings Context and Why It Matters

Atomera Incorporated is a semiconductor materials and technology licensing company built around its proprietary Mears Silicon Technology (MST), which aims to improve the performance and power efficiency of transistors. Because the company is still transitioning from engineering-services revenue to commercial royalty agreements, its quarterly results are driven less by top-line sales and more by cash runway, customer progress, and operating-expense discipline. For investors, this report matters as a progress check on whether Atomera can convert technical validation with major chipmakers into repeatable, royalty-bearing license deals. The third-quarter update also arrives amid strong industry demand for advanced logic, memory, and RF components tied to artificial intelligence, raising the stakes for Atomera's GAA, DRAM (dynamic random-access memory), and GaN initiatives.

Reported Results

For the third quarter ended September 30, 2026, Atomera reported a net loss of $6.0 million, or ($0.15) per basic and diluted share, compared with a net loss of $5.6 million, or ($0.17) per share, in the third quarter of 2025. Revenue was $0, versus $11,000 in the prior-year quarter and $158,000 in the second quarter of 2026. The ($0.15) per-share loss came in wider than the roughly ($0.12) consensus estimate tracked by market data providers, while revenue of $0 fell short of the approximately $100,000 some analysts had modeled.

Adjusted EBITDA, a non-GAAP (non-generally accepted accounting principles) measure, was a loss of $4.6 million, compared with a $4.4 million loss a year earlier. The company held $34.8 million in cash, cash equivalents, and short-term investments as of September 30, 2026, and reported 39.1 million shares outstanding. On the operational side, management highlighted an expansion to three GAA customer engagements, a joint development agreement with IQE targeting high-performance, lower-cost RF GaN, and progress on a simpler, lower-cost approach for next-generation DRAM transistors.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking semiconductor names like Atomera, the tool offers a streamlined way to surface ideas grounded in data-driven signals.

Market Reaction and Investor Sentiment

The market's response to Atomera's third-quarter update was shaped less by the modest widening of its per-share loss than by the absence of revenue and the pace of commercialization. Reports following the release indicated the stock traded lower as the reported ($0.15) loss per share missed the consensus estimate and revenue came in at $0. For a pre-revenue licensing company, investor sentiment tends to hinge on customer traction and cash runway rather than quarterly earnings alone, and the newly signed IQE joint development agreement and expanded GAA engagements provided some offsetting positives. Net-net, the market appears to be weighing continued technical progress against the reality that meaningful royalty revenue has yet to materialize.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors should watch whether Atomera can convert its growing customer engagements into signed joint development agreements and, ultimately, commercial license and royalty contracts. Management has pointed to a broadening pipeline across advanced logic, DRAM, RF GaN, and power applications, but the timing of revenue recognition remains uncertain and largely outside the company's control.

Operating-expense discipline and cash runway will also be in focus. The company ended the quarter with $34.8 million in cash and short-term investments, and management has previously indicated this is sufficient to fund operations for an extended period. Still, rising tool-leasing and service-provider costs flagged on recent calls could pressure the expense base into 2027.

Finally, industry dynamics tied to artificial intelligence and advanced-node transistor scaling remain a key backdrop. Progress in GAA customer evaluations, DRAM cost-reduction efforts, and RF GaN performance milestones will be the clearest signals of whether Atomera's technology is moving closer to revenue-generating adoption.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations